Arbutus Biopharma Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 11/14/2025 | 24.45 M | $111.01 M | 1.19% | 12.76% |
| WHITEFORT CAPITAL MANAGEMENT, LP | 11/14/2025 | 13.34 M | $60.58 M | 0.00% | 6.97% |
| BLACKROCK, INC. | 11/12/2025 | 12.68 M | $57.56 M | -1.49% | 6.62% |
| TWO SEAS CAPITAL LP | 11/14/2025 | 10.99 M | $49.90 M | 5.25% | 5.74% |
| VANGUARD GROUP INC | 11/07/2025 | 8.99 M | $40.82 M | -1.03% | 4.69% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 5.01 M | $22.77 M | 94.68% | 2.62% |
| STATE STREET CORP | 11/14/2025 | 4.10 M | $18.61 M | -8.10% | 2.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.67 M | $16.65 M | 0.80% | 1.91% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.90 M | $13.18 M | 2.74% | 1.52% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.17 M | $9.87 M | -28.50% | 1.13% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.17 M | $9.83 M | -13.31% | 1.13% |
| BLACKBARN CAPITAL PARTNERS LP | 11/14/2025 | 2.00 M | $9.08 M | -23.18% | 1.04% |
| FOURSIXTHREE CAPITAL LP | 11/14/2025 | 1.98 M | $8.98 M | -22.62% | 1.03% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 1.58 M | $7.15 M | 0.00% | 0.82% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.45 M | $6.59 M | 21.14% | 0.76% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 1.34 M | $5.97 M | 0.00% | 0.70% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.29 M | $5.85 M | 0.40% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.27 M | $5.79 M | 1.68% | 0.67% |
| FOURWORLD CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.02 M | $4.63 M | -16.78% | 0.53% |
| CITIGROUP INC | 11/10/2025 | 845.00 K | $3.84 M | 138.10% | 0.44% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 840.00 K | $3.81 M | -2.89% | 0.44% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2025 | 800.00 K | $3.63 M | -17.10% | 0.42% |
| ABRDN PLC | 11/07/2025 | 799.98 K | $3.63 M | -18.58% | 0.42% |
| UBS GROUP AG | 11/13/2025 | 774.59 K | $3.52 M | 307.24% | 0.40% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 765.26 K | $3.47 M | 27.45% | 0.40% |
| SABA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 678.77 K | $3.08 M | -46.13% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 528.34 K | $2.40 M | 5.78% | 0.28% |
| DIADEMA PARTNERS LP | 11/14/2025 | 516.30 K | $2.34 M | 100.00% | 0.27% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2025 | 514.51 K | $2.34 M | 10.76% | 0.27% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 514.08 K | $2.33 M | -3.29% | 0.27% |
| WESTERN STANDARD LLC | 11/12/2025 | 507.85 K | $2.31 M | 100.00% | 0.27% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 505.10 K | $2.29 M | 12.45% | 0.26% |
| FREESTONE CAPITAL HOLDINGS, LLC | 11/12/2025 | 442.50 K | $2.01 M | 0.00% | 0.23% |
| CITIGROUP INC | 11/10/2025 | 439.20 K | $1.99 M | 46.45% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 399.15 K | $1.81 M | 8.95% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 372.10 K | $1.69 M | 38.22% | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 310.05 K | $1.41 M | 18.22% | 0.16% |
| JANE STREET GROUP, LLC | 11/14/2025 | 300.46 K | $1.36 M | 34.86% | 0.16% |
| BARCLAYS PLC | 11/12/2025 | 284.33 K | $1.29 M | -30.06% | 0.15% |
| LEDGEWOOD WEALTH ADVISORS, LLC | 10/24/2025 | 278.44 K | $1.26 M | 0.00% | 0.15% |
| SWISS NATIONAL BANK | 11/13/2025 | 276.30 K | $1.25 M | 0.00% | 0.14% |
| NUVEEN, LLC | 11/12/2025 | 257.93 K | $1.17 M | -37.28% | 0.13% |
| ROYAL BANK OF CANADA | 11/14/2025 | 236.83 K | $1.08 M | -11.36% | 0.12% |
| MURCHINSON LTD. | 11/14/2025 | 222.90 K | $1.01 M | 100.00% | 0.12% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 215.04 K | $976.29 K | -41.57% | 0.11% |
| RHUMBLINE ADVISERS | 11/06/2025 | 211.78 K | $961.49 K | 1.91% | 0.11% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 211.50 K | $960.21 K | 2,174.19% | 0.11% |
| INVESCO LTD. | 11/13/2025 | 209.64 K | $951.76 K | 15.77% | 0.11% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 205.39 K | $932.46 K | 100.00% | 0.11% |
| MURCHINSON LTD. | 11/14/2025 | 200.00 K | $908.00 K | 100.00% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arbutus Biopharma Corporation institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:
MORGAN STANLEY: 24.45 M
Whitefort Capital Management, LP: 13.34 M
BlackRock, Inc.: 12.68 M
Two Seas Capital LP: 10.99 M
VANGUARD GROUP INC: 8.99 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.01 M
61.70% of Arbutus Biopharma Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 133.37 M shares in the last 24 months. This purchase volume represents approximately $588.14 M in transactions.